Figure 1 — The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials

Navigate

Research Paper|Volume 13, Issue 16|pp. 20468–20480

The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials

Back to articleFigure 1(1 of 4)

100%

Figure 1.Flow chart of the study selection procedure.

Figure 1 — The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials | Aging